Dr. Robert Califf has been narrowly confirmed as commissioner of the US FDA in a final Senate vote of 50 to 46. The verdict has been met with controversy, with some questioning his pharmaceutical connections. Additionally, industry organizations are now calling for key action items to be addressed, such as better funding and guidance for certain ingredients.
Following the acquisition of Nattopharma, Gnosis by Lesaffre’s managing director Marc Philouze details the company’s approach to further expansion. Innovation is a key priority, which means companies that can offer new ingredients or products are especially appealing as partners.
